As a next step, we evaluated the RNA levels of the two genes of interest, SSTR5 and SSTR5‐AS1, in the same cohorts of somatotropinoma and NP samples (Fig. 1C). This evidence concerns the gene SSTR5 and growth hormone-producing pituitary gland neoplasm.